ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1572

Ultrasound Signs of Gout in a Population with Asymptomatic Hyperuricemia

Bilal Bengana1, Aicha Ladjouze2, Nabil Baramtane Raaf3, Chaffa Aimeur4, Soraya Ayoub5, Abdenour Boukabous6 and Salima Lefkir-Tafiani7, 1University Hospital of Beni Messous Algiers - Rheumatology Department, Algiers, Algeria, 2Specialized hospital establishment of Benaknoune, Rheumatology, Algiers, Algeria, 3Hospital of Bitraria, Biochemistry, El Biar, Algiers, Algeria, 4University hospital of Mustapha Bacha, Radiology, Sidi Mhamed, Algiers, Algeria, 5University hospital of Beni Messous, Internal Medicine, BeniMessous, Algiers, Algeria, 6University Hospital of Beni Messous Algiers- Rheumatology Department, Algiers, Algeria, 7University Hospital of Beni Messous Algiers - Rheumatology Department, Benimessous, Algeria

Meeting: ACR Convergence 2021

Keywords: gout, hyperuricemia, Ultrasound, Uric Acid, Urate

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Session Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II (1565–1583)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Hyperuricemia is a common biological abnormality, often clinically asymptomatic. However, it can announce a gout and be linked to many diseases such as metabolic syndrome, high blood pressure or kidney disease. In fact, the majority of learned societies do not recommend any urate lowering therapy (ULT) as long as the hyperuricemia remains asymptomatic. But it turns out that part of the population with asymptomatic hyperuricemia (AH) develops a gout after a few years particularly with genetic predisposition, but also on certain risk factors that need to be confirmed. By this way, musculoskeletal ultrasound (MUS) can detect “asymptomatic gout” by visualizing signs of urate deposits (UD) in subjects with AH.

Our main objective is already to estimate the prevalence of specific signs of gout in Algerian population with AH and assess the factors exposing to UD.

Methods: This is a descriptive cross-sectional study from January 2017 to February 2019, with the recruitment of subjects with AH and serum urate level > 360 µmol/l (6 mg/dl), who do not take any ULT and have not associated any chronic inflammatory rheumatism, where we performed a MUS of the knees, metatarsophalangeal joints MTP1, MTP2 and metacarpophalangeal joint MCP2 and MCP3 with the Achilles, patellar and quadricipital tendons.

Results: We retained 258 subjects with AH, 132 women and 126 men (sex ratio = 0.95), the mean age was 59 years, the mean body mass index (BMI) was 28.4 kg / m2, 42 patients were under diuretics, 37 patients reported being on low-dose of aspirin 100 mg daily. The mean rate of serum urate levels was 460 ± 6 µmol/l , the prevalence of UD found at the MUS was 22% (n = 58), among them 36 % (21/58) had a sign of the double contour DC on the MTP1 and 29% (17/58) on the knee, 7% (4/58) had tophi on the MTP1 and 3% (2/58) had urate aggregates.

The factors reported to be linked to UD in the sample were: the male gender (p = 0.0016); the high uric acid level (p= 0.0355); BMI (p = 0.0427); taking diuretics for women (p= 0.0002).

Conclusion: Through this work, it is clear that elementary ultrasound lesions related to gout disease are common in a population with AH and concerned one fifth of subjects in our study with a higher risk in men and subjects with obesity and high uric acid level, but also in women taking diuretics. These results need to be enhanced with a randomized controlled study in order to better determine the predisposing factors for gout in any subject with AH.


Disclosures: B. Bengana, None; A. Ladjouze, None; N. Raaf, None; C. Aimeur, None; S. Ayoub, None; A. Boukabous, None; S. Lefkir-Tafiani, None.

To cite this abstract in AMA style:

Bengana B, Ladjouze A, Raaf N, Aimeur C, Ayoub S, Boukabous A, Lefkir-Tafiani S. Ultrasound Signs of Gout in a Population with Asymptomatic Hyperuricemia [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/ultrasound-signs-of-gout-in-a-population-with-asymptomatic-hyperuricemia/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-signs-of-gout-in-a-population-with-asymptomatic-hyperuricemia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences